This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Effects of Betaine Supplementation on Strength and Muscle Creatine Content

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bruno Gualano, University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT01213719
First received: October 1, 2010
Last updated: January 12, 2012
Last verified: January 2012
  Purpose
It has been suggested that betaine supplementation may improve muscle strength by increasing muscle creatine content. However, there is no data supporting this assumption. The investigators speculate that betaine supplementation could enhance intramuscular creatine content, which would result in strength improvements.

Condition Intervention
Healthy Subjects Dietary Supplement: creatine Dietary Supplement: betaine Dietary Supplement: dextrose Dietary Supplement: creatine plus betaine

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Official Title: Effects of Betaine Supplementation Combined or Not With Creatine Supplementation on Muscle Creatine Content and Strength

Resource links provided by NLM:


Further study details as provided by Bruno Gualano, University of Sao Paulo:

Primary Outcome Measures:
  • strength [ Time Frame: after 10 days ]

Secondary Outcome Measures:
  • intramuscular creatine content [ Time Frame: after 10 days ]

Enrollment: 40
Study Start Date: October 2010
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: creatine
will receive creatine monohydrate (20g/d) throughout 10 days
Dietary Supplement: creatine
20g/d throughout 10 days
Experimental: betaine
will receive betaine (2g/d) throughout 10 days
Dietary Supplement: betaine
2g/d throughout 10 days
Placebo Comparator: placebo (dextrose)
will receive dextrose(20g/d)throughout 10 days.
Dietary Supplement: dextrose
dextrose (placebo), 20 g/d throughout 10 days
Active Comparator: creatine plus betaine
will receive creatine (20g/d) plus betaine (2g/d) throughout 10 days
Dietary Supplement: creatine plus betaine
creatine (20g/d) plus betaine (2g/d) throughout 10 days

  Eligibility

Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • physically inactive
  • non-obese

Exclusion Criteria:

  • skeletal muscle disturbance
  • cardiovascular disturbance
  • use of dietary supplements
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01213719

Locations
Brazil
University of Sao Paulo
Sao Paulo, Brazil, 05508-030
Sponsors and Collaborators
University of Sao Paulo
Investigators
Study Director: Bruno Gualano, PhD University of Sao Paulo
  More Information

Responsible Party: Bruno Gualano, Principal Investigator, University of Sao Paulo
ClinicalTrials.gov Identifier: NCT01213719     History of Changes
Other Study ID Numbers: betaine supplementation
Study First Received: October 1, 2010
Last Updated: January 12, 2012

Keywords provided by Bruno Gualano, University of Sao Paulo:
betaine, creatine, strength

Additional relevant MeSH terms:
Betaine
Gastrointestinal Agents
Lipotropic Agents
Hypolipidemic Agents
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Lipid Regulating Agents

ClinicalTrials.gov processed this record on September 21, 2017